AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Herhope 150mg Injection

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Trastuzumab (150mg)

Overview Herhope 150mg Injection

Oncaspar 150mg Injection treats breast and gastric cancers by targeting and destroying cancerous cells through HER2 (human epidermal growth factor receptor 2) inhibition. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and infections. A reduction in blood cell counts (red and white blood cells), increasing infection risk, is possible, necessitating regular blood tests to monitor blood cell levels, cardiac function, hepatic function, and uric acid levels. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all medications you are taking, as interactions may occur. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.

Primary Ingredients of Herhope 150mg Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Herhope 150mg Injection

Malignancies affecting the breast and stomach.

Major Benefits of Herhope 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Herhope 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Herhope 150mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Herhope 150mg Injection works:

Herhope 150mg Injection, a recombinant IgG1 monoclonal antibody, targets HER2 (human epidermal growth factor receptor 2) receptors. By binding to these receptors, it prevents the uncontrolled growth of breast and gastric cancer cells. This action halts HER2-driven proliferation and disrupts multiple downstream signaling cascades implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Herhope 150mg Injection and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Herhope 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Herhope 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Herhope 150mg Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Herhope 150mg Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Herhope 150mg Injection to individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Herhope 150mg Injection :

Should you forget a dose of Herhope 150mg Injection, seek your physician's advice.

Facts to Know About Herhope 150mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Actions Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Herhope 150mg Injection

Herhope 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception is recommended for women of childbearing age throughout Herhope 150mg Injection therapy and for seven months afterward. Pregnancy planning can resume seven months post-treatment.
Early-stage breast cancer patients should receive Herhope 150mg Injection for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herhope 150mg Injection does not require fasting before administration. It must be administered by a qualified healthcare professional, under the supervision of a doctor experienced in cancer chemotherapy.
Herhope 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the product label to ensure correct administration. The IV formulation is exclusively for intravenous infusion; it must not be given subcutaneously. Your doctor might change your Herhope 150mg Injection treatment from IV to SC, or vice versa, if clinically appropriate.
Herhope 150mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. It inhibits cancer growth by binding to HER2. Consequently, this injection is only effective in HER2-positive patients and is not indicated for those with HER2-negative cancer.
Using Herhope 150mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations are necessary at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the final Herhope 150mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Herhope 150mg Injection
24,243